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Abstract
Partners in Health's (PIH) supply chain in Haiti has become strained over the past five years due
to the organization's rapid growth. Under the current system, the majority of PIH's products are
obtained through an annually placed order. All goods from this order are stored at the central
warehouse in Cange, which acts as a hub, until those goods are needed at individual clinics. As
annual orders increase in size to support PIH's expanding operations, the limited size of the
central warehouse has become a constraint, making a change in current inventory policies
necessary. In order to formulate revised inventory policies for PIH's Haiti operations, we
developed a spreadsheet model that uses historical consumption data of drugs and medical
supplies to forecast demand over the next three years. This demand data is then be used as input
to run and compare the existing annual order policy with ordering policies with more frequent
reviews. These inventory policies are then evaluated against the central warehouse size
constraints to recommend an inventory policy better suited to meet PIH's needs. We find that
more frequent orders drastically reduces warehouse space requirements while maintaining high
service levels. It is hoped that PIH can continue to use this model to determine future inventory
policy needs.
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1 Introduction
Partners in Health (PIH) is a global non-profit health care provider. PIH's work began in
the impoverished Central Plateau of Haiti with its Zanmi Lasante ("Partners in Health" in Haitian
Kreyol) project. What started as a small medical clinic in Cange in 1985 is now a large
healthcare complex. The size of PIH's network has since increased to nine additional sites
throughout Haiti, with Port Au Prince functioning as a cross dock for PIH goods coming into the
country (Figure 1). Care is provided free of charge and all patients are accepted. At least two
additional sites, one in Mirebalais and one in Verrettes are planned for the near future.
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Figure 1: PIH Haiti Existing and Proposed Sites
Source: PIH Haiti ZL Site Map, Google Maps
.. .... . .... . .
In the past five years, the number of PIH's clinics in Haiti has nearly doubled, and the
number of annual patient encounters has nearly tripled to 2.6 million. PIH's supply chain and
inventory strategies, however, have not been altered to accommodate this significant growth. As
a result, the supply chain has become strained. Under its current inventory policy, the majority of
PIH's products are obtained through an annually placed order. The shipment from this order is
received sporadically over the next several months, with the final shipment sometimes not
arriving for eight months. Because the products are shipped from the main supplier, International
Dispensary Association Foundation (IDA), as they become available, sometimes several
containers of product will arrive at once. In one instance, seven containers arrived
simultaneously.
All products are stored at a central warehouse located in Cange prior to their distribution
to other sites. There have been several incidents recently in which the volume of products
coming into the central warehouse has exceeded the storage space there. When the volume of
goods arriving at the central warehouse exceeds the storage capacity, the goods must be placed at
any sites with available space, making it difficult to accurately track and distribute these goods to
the sites where they are needed.
Research conducted in 2009 by a Harvard Business School student provided an analysis
of PIH's supply chain through review of stockout rates, consumption data, turnover data and
volume calculations. The research concluded that the central warehouse was not sufficiently
sized to handle the volume of goods managed by PIH. While the study suggested several options
for larger or additional central warehouses, it did not provide a modified inventory policy.
The objective of our thesis is to improve the existing supply chain by developing new
inventory policies to support the projected growth of PIH while reducing warehouse volume
requirements and emergency procurement costs. Additionally, in January 2010, a 7.0 Mw
earthquake just outside of Port Au Prince, Haiti's capital and largest city, devastated the region.
While PIH's sites were not damaged in the earthquake, these sites will be subject to much
change in the future. As a result of the earthquake, there is expected to be significant internal
migration to the Central Plateau and beyond. Therefore, PIH will need to adjust our demand
forecast numbers accordingly once it has a good estimate of the population increase in its
catchments areas.
In the seven sections below, we will discuss our approach to improving PIH's supply
chain. In section 2, Literature Review, we survey publications that address for-profit and non-
profit healthcare operations, especially those covering inventory and supply chain challenges. In
section 3, Background-Haiti and PIH Operations, we provide background on Haiti and PIH's
role in providing health services in the country. Section 4, Methods, explains the forecasting and
inventory theories used for our data analysis. In section 5, Data Analysis, the data cleaning is
discussed, and a user guide for the spreadsheet model we developed for forecasting and
inventory analysis is provided. This section also provides an overview of available warehouse
space. In section 6, Results, the findings of our inventory policy review are summarized. In
section 7, Additional Factors, further issues that may affect the inventory policy are discussed.
Finally, in section 8, Recommendations, some additional ideas for ways PIH can improve its
existing supply chain are provided.
2 Literature Review
Our review of the literature included peer-reviewed publications and field guides
developed by public health practitioners. These documents survey current academic research and
summarize practices that do or do not work in developing countries. Although there is no "one
size fits all" answer for health care supply chains in developing countries, our review provides a
context for our analytical techniques.
The application of management science (MS) and operations research (OR) to health care
and pharmaceutical practices is becoming widespread. The literature provides the theory behind
MS and OR techniques and details successful applications of theory-based practices in health
care environments. Carter, Golden and Wasil (2009) surveyed eight successful MS and OR
applications in various sectors of the health care industry. Only one was specific to
pharmaceuticals, however.
HIV treatment in developing countries is a major objective of some NGOs. PIH has
performed much HIV work in Haiti already. One of its early successful interventions in Haiti
was HIV treatment in the Central Plateau. Koenig, Leandre and Farmer (2004) discuss the
successful scale-up of this HIV treatment program. While this paper is a useful reference, much
of the scale-up's success was due to the hiring of accompagnateurs. Accompagnateurs are hired
to work within their home community, and ensure those receiving medical care in their
community are taking their medications per specification and attending scheduled clinic visits.
The article did not clearly address the effect the scale-up had on the pharmaceutical supply chain.
World Health Organization (2004) provides a framework for procurement, storage and
inventory management of drugs in their "Management of Drugs at Health Centre Level" training
manual. Regarding procurement, the concepts of lead time (L), monthly consumption, reorder
points (s) and order-up-to levels (S) are described. Regarding storage, the attributes of the
storeroom environment, arrangement of drugs on the shelf, use of a first in first out (FIFO)
system is discussed. A FIFO system ensures the drugs that were received first should be used
first; as long as more recently received drugs do not have shorter expiration dates. Regarding
stock management, how to track inventory by the use of manual stock cards is discussed. PIH's
current stock monitoring system (a computerized database with internet linkages), is far more
advanced. Therefore, the models explained in the WHO manual are not likely to be pursued.
The role of supply chains in the proper functioning of healthcare system are focused on in
papers by Hicks, Purcell, Raja and Heinen (2009) and Hicks, Raja and Heinen (2009). Levine,
Pickett, Sekhri and Yadav (2008) also address supply chains in healthcare systems, but narrow
their focus to the role of forecasting.
Hicks, Purcell, Raja and Heinen (2009) discuss a scenario in which although significant
financing for drugs and supplies and supply chain operations was available, overstocks and
stockouts were common. The World Bank and Llamasoft were called upon to analyze the issues
in the supply chain. It was fortunate that several years of transaction data was available for
analysis of the 3285 products offered. The system was comprised of a hybrid single echelon and
a two tiered echelon system. This system was evaluated for efficiency using the supply chain
modeling tool Llamasoft. A potential decentralized system and a potential centralized system
were also evaluated. The analysis also studied the 20 most demanded products, the fill rates for
those items, and their largest customers by volume. Overall, fill rate was about 75%. Llamasoft
helped determine that the biggest problems in the system were long lead times and high
variability in these lead times from the supplier. Further investigation revealed that the high
variability in lead times, if improved, would be the greatest source of savings and improvement
in supply chain quality. Llamasoft also helped to determine that a centralized system in which all
goods were shipped from the central storage to the facility, rather than some sites being served
by regional storage facilities, would lower overall costs by about 5%. Other portions of the study
identified poor ordering habits at the hospital level. Rather than using monthly orders to obtain
the majority of their supplies, daily rush orders were the norm. Habits like this are to some extent
fed by the existing supply chain problem, but also the reason these problems in the supply chain
continue. This paper's investigation of over/understock issues, direct vs. regional distribution,
and poor ordering habits at the clinic level parallel several investigations we will be performing
in our own thesis. Our investigation focuses on a smaller product volume, but involves
forecasting future demand and warehouse efficiency.
Hicks, Raja and Heinen (2009) investigated the poor fill rate (21%) within KEMSA
(Kenta Medical Supplies Agency) system. In the system, 1173 products were sourced from three
central warehouses in Nairobi and eight smaller regional depots (though these were mostly used
to hold slower moving items). KEMSA used a push system, in which products were shipped six
times a year to hospitals and four times a year to health centers. In KEMSA's view, its current
warehouse system was at capacity. The focus of the analysis was to determine whether the
system should be decentralized, and whether the push system was the most effective for the
system's needs. The decentralization study looked at six scenarios, including the existing
scenario (one centralized DC), converting all existing regional depots to DCs, and conducting a
"Greenfield" analysis to determine the optimum location of a single warehouse. Analysis
revealed that while adding regional warehouses would reduce transportation costs significantly,
the savings would be partially offset by higher inventory costs. It was determined that the
addition of one regional DC would be a good balance. An analysis was then run eight times at
potential locations to determine the ideal location for this DC. While the other goal of the
analysis had been to compare use of a pull system vice a push system, it was determined that the
shortage issue was so severe that it should be investigated instead. The analysis confirmed that
warehouse space was an issue, as increasing the fulfillment rate from 21% to 100% would
require warehouse space to increase to two to three times. As for improving service rate, demand
variability was a major culprit, and a significant increase in inventory would be needed to
overcome this variability and achieve a 100% service rate. Overall, the study determined that
inadequate financing was the root of the problem, and that additional funds were essential to
make the supply chain more efficient. The fact that forecasted demand was not accounted for
makes the 21% fulfillment rate even more alarming, if not action is taken. This paper reflects
many of the concepts we analyze in our thesis, especially its investigation of adequate warehouse
space.
Levine, Pickett, Sekhri and Yadav (2008) discuss the importance of reliable demand
forecasts for global health programs. Viewing a reliable forecast as critical in the success of a
supply chain, the paper elaborates on the effect a poor forecast can have on the entire supply
chain. One example given was a pharmaceutical company overproducing a drug based on an
inaccurate forecast from a global health program.
While this paper was relevant to our research as it addresses the importance of
forecasting, it focuses more on the effects of forecasting further upstream the supply chain than
our thesis does. Many examples are cited where the supplier is greatly affected. In our thesis
forecasting is important further downstream, to PIH itself. An accurate forecast will allow PIH to
better determine demand, and therefore select the most appropriate inventory policy based on
that demand.
Morreale and Prichard (1995) provide rules of thumb for logistics topics ranging from
transportation to inventory to warehousing. The inventory subjects addressed included inventory
levels, service levels, and carrying costs. The guidance provided on warehousing was of
particular interest to us. Information included such topics as storage capacity, rack layout, aisle
arrangement, available space and cube utilization. The concepts behind available space and cube
utilization will be important in our evaluation of the central warehouse.
While the running, improvement, and scale-up of healthcare systems are common
subjects in peer-reviewed publications and field guides, most of them do not focus on supply
chain improvement. Even fewer address the importance of forecasting within the context of
supply chain improvement. In our thesis, we use forecasting to develop more appropriate
inventory policies for PIH while remaining cognizant of the constraints of warehouse size.
3 Background- Haiti and PIH Operations
PIH has been active in Haiti for over twenty years. This section provides a basic
background on Haiti and on PIH's efforts there. Current and proposed PIH sites are discussed, as
are PIH's existing system for distributing goods throughout that system. Finally, sources of
PIH's goods are discussed.
3.1 Haiti
Haiti occupies the western portion of the Caribbean island of Hispaniola. Haiti has long
suffered from political violence and poverty, and is considered the poorest country in the
Americas. The current population is approximately 9 million. The largest city, and capital, is Port
Au Prince. Haiti is divided into ten departments, including the Artibonite and Centre departments
that PIH serves (Figure 2). Haitian Creole and French are the official languages. PIH operates
eight sites in the Central Plateau and two sites in the Artibonite region of Haiti.
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Figure 2: The Ten Departments of Haiti
<http://upload.wikimedia.org/wikipedia/commons/d/de/Haiti-departments-named.png>
3.2 PIH Sites
PIH operates eight sites throughout the Central Plateau of Haiti: Belladere, Boucan Carre,
Cange, Cerca La Source, Hinche, La Colline, Lascahobas and Thomonde. PIH also operates two
sites in the Artibonite region: Petite Riviere and Saint Marc. Facilities vary at each site, as
described below in Table 1.
Table 1: PIH Haiti Sites, By Region
Central Plateau Sites
Site Name Medical Facility Type Storage Facility Type Comments
Belladere clinic storage space
Boucan Carre clinic (small) storage space difficult to reach due to poor road conditions
Cange Sociomedical Complex warehouse
Cerca La Source hospital warehouse remote site
Hinche hospital warehouse (large)
La Colline hospital (new, full service storage space also acts as main storage for Lascahobas
Lascahobas women's health facility storage space ten minutes from La Colline
Thomonde clinic (small) storage space (limited)
Artibonite Sites
Site Name Medical Facility Type Storage Facility Type
Petite Riviere clinic (small) storage space (limited)
Saint Marc hospital (large) warehouse (large)
Future sites will likely be established in Mirebalais (Central Plateau) and Verrettes
(Artibonite) to address the need for health care services in these areas. In addition, a large
warehouse may also be located in Mirebalais.
All PIH products are shipped into Port Au Prince, which is located in the Quest
department (Figure 3). Prior to the earthquake, PIH operated one small facility in Port Au Prince.
This facility acted as a cross dock for goods received. Goods were not stored at this facility, but
instead were moved to the warehouse located in Cange.
PIH currently only ships goods into Port Au Prince because of the excellent relationship
they maintain with customs at that port. While the use of additional ports has been discussed, it is
uncertain whether the organization would be able to develop good relationships in customs at
new ports. Post-earthquake, PIH is renting a large facility in Port Au Prince. It has yet to be
determined if such a facility will become permanent.
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Figure 3: Port Au Prince
<http://en.wikipedia.org/wiki/File:Haitimap.png>
PIH's main site in Haiti is located in Cange. Named the Sociomedical Complex, it is
compromised of a full-service hospital (104 beds), an infectious disease center, an outpatient
clinic, a women's health clinic, a laboratory, a Red Cross blood bank, radiographical services,
and a large warehouse. As discussed previously, the warehouse in Cange acts as a "central"
warehouse. All goods are stored at the Cange warehouse until one of the ten regional sites
requests a need for them. They are then transported to that site.
3.3 Shipping and Transportation
The majority of products are shipped to PIH by container ship. This is a cost effective
method of sending goods but also has the longest lead time. Some shipments are also made by
air, either as air-freight, or carried in suitcases by PIH staff when traveling to Haiti.
Transportation between the central warehouse in Cange and the regional sites is adequate,
but could benefit from some improvement. Currently, goods are transported between the central
warehouse and the regional sites on a weekly or bi-weekly basis. PIH does not own the majority
of these vehicles but rather rents them. This is due in part to the high maintenance required on
vehicles that travel unpaved roads of rural Haiti. PIH staff also report that the trips are often
made with less than a full load, even when multiple sites could be serviced on the same trip.
3.4 Sources of Goods
Approximately two-thirds of the products in our analysis are supplied by IDA. IDA is the
world's leading non-for-profit supplier of affordable pharmaceutical products. PIH places an
annual order with PIH in July each year.
PIH also orders goods through McKesson Surgical, Brigham and RxElite. PIH receives
in-kind donations as well. Emergency orders are often sourced locally from Haiti or Dominican
Republic. PIH also sources some infant formula locally due to storage constraints in the central
warehouse. Tuberculosis and AIDS drugs are also obtained outside the IDA order.
4 Methods
In order to assess and improve upon the existing supply chain, we looked to PIH's
historical demand data. We then chose an appropriate demand forecasting method, and
developed inventory policies based on forecasted demand.
In order to describe our process, we first review three common demand forecasting
methods: simple exponential smoothing, exponential smoothing with trend, and the Holt-Winters
Smoothing Procedure. We then discuss selection of an appropriate forecast method for PIH, and
application of this method to an appropriate inventory policy.
4.1 Demand Forecasting: Background
The exponential smoothing approach to demand forecasting is the most appropriate for
our research. Exponential smoothing models are preferable to regression models since they give
greater weight to recent data. Silver, Pike and Peterson (1998) discuss three exponential
smoothing methods.
Simple exponential smoothing:
Underlying model: xt = at + et (1)
Where: t,t& I= axt + (1-a) dt-1,t (2)
This model incorporates historical data into projections. Demand is a function of level (a)
plus an error term. Higher values of alpha, which ranges from 0 to 1, give more weight to recent
demand data. For these equations the "hat" symbol (^) indicates a predicted value for the given
variable. In this model, t-1,t is the projected level of a at time (t), based on the projected level at
time (t-1) (Silver, Pyke and Peterson 89).
Exponential smoothing with trend:
Underlying model: xt= at + btt + et (3)
Where: at,t+i atxt + (1-a)( dt-I + bt.1) (4)
b= p(dt - dt-±) + (1- P) b1_- (5)
This model builds on simple exponential smoothing by incorporating a trend component
(b), which represents the linear increase of demand over time. This approach is appropriate for
data in which demand changes linearly over time (Silver, Pyke and Peterson 93). Higher values
of beta make the slope component of the model more sensitive to recent changes in demand. The
model assumes that demand patterns are somewhat smooth. Although this approach is an
improvement upon the simple smoothing model, it is still inappropriate for products with
seasonal demand fluctuations.
Holt-Winters Smoothing Procedure:
Underlying model: xt= (at + btt)Ft + et (6)
Where: 1,141= a(xFt/pt-p) + (1-a)( 51- + bt-1) (7)
bt = pf(dt - a5t-) + (1- )bt.I (8)
Ft = y(xt/±) + (1 - y)Ft-p (9)
The Holt-Winters Smoothing Procedure builds on exponential smoothing with trend by
incorporating a seasonality component (F). This approach is particularly useful for medical
products, such as antimalarials, for which demand peaks during certain times of the year. F is a
function of current demand divided by a moving average of demand. Pt-p is the value of F at the
same time in the preceding period. A period is the length of time of a demand cycle. For
instance, if demand has an annual cycle, the period is 12 months, or 1 year. Higher values of
gamma give greater weight to recent demand in the seasonality equations.
4.2 Demand Forecasting: Application
The Holt-Winters method was chosen for forecasting PIH's product demand, as demand
for some of PIH's products follows a seasonal pattern. Three years (January 2007- December
2009) of historical data were used to forecast demand. Although product demand is somewhat
constant across years, it is volatile from month-to-month. For this reason, instead of using the
equation F = (current month's demand / moving average of demand), the numerator in our
equation is average demand over a four month period. This time period was chosen to decrease
the fluctuations in F, while still allowing some variability over a given year. We use a moving
average of 12 months in the denominator of this equation to capture the average monthly demand
over a year.
PIH's catchment areas experienced significant internal migration in early 2010 as a result
of the Port au Prince earthquake. PIH estimates this migration will cause demand for its service
to permanently increase, but does not currently have an estimate for the percent increase.
4.3 Inventory Policies
Currently, PIH places annual orders for its drugs and supplies (PIH staff, personal
communication, February 19, 2010). Limiting orders to one annual shipment decreases the
complexity of the order management process, but can greatly increase inventory costs. More
importantly, PIH's limited warehouse capacity makes it difficult to properly store and monitor
large incoming shipments. This lack of storage space will become a more pressing issue as PIH
continues to expand its operations and treat more patients. We therefore investigated the benefits
of adopting different inventory policies and order frequencies. The focus of our research is the
impact on volume requirements and emergency procurement costs from inventory policy
changes. The financial implications of holding excess inventory are not a paramount concern to
PIH since it is a non-profit organization.
Since PIH lacks a sophisticated inventory monitoring system, which is discussed in
section 7, Additional Factors, we use a periodic review policy for drugs and supplies.
Furthermore, periodic reviews allow for easier coordination of several items since orders are
placed at the same time for all products (Silver, Pyke and Peterson 241). For this study, we place
each product into prioritization categories of A and B. A-items are the most important products
and thus maintain higher safety stocks to lower the probability of stocking out. For both category
A- and B-items, an (R, s, S) policy is used. Under the (R, s, S) policy, inventory is checked after
a set period of time (R) and orders are placed when inventory is below the reorder point (s),
whereby:
s = XL+R± k*OL+R (10)
X(L+R) is demand over lead time (L) and the review period (R), k is a safety factor and
GL+R is the deviation of demand over lead time and the review period. k*a(L+R) is the safety stock,
and a higher k corresponds to a higher safety stock (Silver, Pyke and Peterson 245). A-items
products are assigned higher k values in order to minimize stockouts. The default k values are
2.33 and 1.65 for A- and B-items, respectively.
The order quantity is equal to the difference of (S - current inventory - in-transit
inventory) at time of the order (Silver, Pyke and Peterson 241). Order quantities under periodic
review systems are difficult to optimize. Therefore we devise S as a multiple of s with the
multiple being greater than or equal to 1.
Since demand is not constant across months, S changes each review period. X(L+R)
depends on the expected demand over the upcoming lead time and review period, while a(L+R) is
constant, since variance takes into account all periods of historical demand. Additionally, the
order quantity is rounded up to the nearest unit size for practical purposes, since a supplier will
not accept an order for a fraction of a package. For example, if a unit or box of penicillin consists
of 100 individual pills, then an order quantity of 255 will be rounded up to 300 pills.
For our model, we use a monthly review policy (R = one month) for PIH's products. A
shorter review period would be too onerous for PIH given the resources required to conduct an
inventory check and place orders (PIH staff, personal communication, March 30, 2010). A
review period of greater than one month, however, would lead to greater storage requirements.
We also analyze longer review periods in case monthly orders are too demanding for PIH staff in
Haiti.
The initial inventory level set to is X(L+R)± k*G(L+R), or the reorder point. This level was
chosen so that each product would be ordered in month two while maintaining sufficient stock
for a significant time. The inventory is checked for each product on monthly basis since R = 1. If
the current inventory position is below the reorder point, a new order is placed. The inventory
position is equal to the physical inventory in the warehouse plus the in-transit inventory. In-
transit inventory consists of products that have been ordered, but have yet to arrive in the
warehouse.
The importance of taking in-transit inventory into account is best explained through a
simple example. Assume L = three months, and that for a certain product s = 1000, S = s,
monthly demand is 200 and the initial inventory is 1200. If orders are based solely on physical
inventory levels, organizations will make excess purchases until the original order is actually
received in the warehouse. The table below illustrates how not incorporating in-transit
inventories for order placements causes large, unnecessary spikes inventory levels.
Table 2: Comparison of
ordering based on Physical Inventory
Physical Inventory Order Order
Inventory Position Quantity In-transit Arrival Demand
1200 0 0 0 0 200
1000 1000 0 0 0 200
800 800 200 200 0 200
600 800 400 600 0 200
400 1000 600 1200 200 200
400 1400 600 1600 400 200
600 1800 400 1600 600 200
1000 2000 0 1000 600 200
1400 1800 0 400 400 200
1600 1600 0 0 0 200
1400 1400 0 0 0 200
1200 1200 0 0 0 200
Reorder Point References
Ordering based on inventory Position
Physical Inventory Order Order
inventory Position Quantity In-transit Arrival
1200 0 0 0 0
1000 1000 0 0 0
800 800 200 200 0
600 800 200 400 0
400 800 200 600 200
400 800 200 600 200
400 800 200 600 200
400 800 200 600 200
400 800 200 600 200
400 800 200 600 200
400 800 200 600 200
400 800 200 600 200
As mentioned previously,
each product. Forecasted demand
forecasted demand is
is also used to derive
used to determine inventory
simulated demand, where:
policies for
Simulated demand =forecasted demand + Z*standard deviation of demand (11)
Z is the z-score corresponding to a randomly chosen probability of 0 to 1. In our simulations,
demand is equal to simulated demand. Simulated demand is utilized to test the robustness of
inventory policies regarding stockouts and warehouse volume requirements, the primary
Demand
200
200
200
200
200
200
200
200
200
200
200
200
objectives of our research. A stockout occurs whenever PIH's inventory is not sufficient to meet
demand for a given product.
Simulations are run under numerous lead time and review period scenarios. The current
lead time for PIH's orders is four months, which is the default in our model. We also vary R
from one month, three months and six months. Finally we compare these results of these review
periods to those from annual orders. Below are the seven scenarios under which we run
simulations.
Scenario 1: Monthly orders, S = s, L = 4 months
Scenario 2: Quarterly orders, S = s, L = 4 months
Scenario 3: Semi-annual orders, S = s, L = 4 months
Scenario 4: Monthly orders, S = s, L = 2 months
Scenario 5: Quarterly orders, S = s, L = 2 months
Scenario 6: Semi-annual orders, S = s, L = 2 months
Scenario 7: Annual orders, Q = D + kayear
For annual orders we assume that all products arrive in January and that order quantity is
equal to expected annual demand + k*monthly sigma*sqrt(12). For each scenario, we capture
inventory volume, emergency procurement costs and the number of shipping containers arriving
in Port au Prince over 250 simulations.
Product volume is the individual cubic meters of a product multiplied by the number of
individual units for that product. The volumes of all products are summed to tabulate the
monthly required storage space for the warehouse. The storage space at the central warehouse is
limited, and therefore the maximum volume associated with an inventory policy would have to
take this constraint into account.
The financial analysis of our research focuses on stockout costs, since they are tangible
expenses born by PIH. In the private sector, a stockout often results in a lost sale. In the public
health environment, though, there are no "lost" sales. First, there is the component of human
suffering or possible death associated with a patient not receiving a necessary drug. Furthermore,
PIH must locally source depleted products from Haiti or have them flown in. Both actions place
significant financial burdens on PIH. The cost of stockout is B2*product value, where B2 is the
markup or penalty from buying locally or flying a product from Boston compared to normal cost
of receiving a product via ship. For this analysis we assume a stockout penalty of 50%, which is
the average markup for locally procured drugs and supplies in Haiti.
Theoretically, stockouts will decrease with shorter lead times and more frequent orders
because PIH can respond more rapidly to low inventory levels. It will also have more numerous
opportunities, rather than just one annually, to place orders through its primary suppliers. Our
research tests whether this correlation between stockouts and lead times and order frequency
holds.
It is important to analyze both lead times and order frequency since they may be
negatively correlated. Currently PIH's suppliers only send shipments when the entire quantity is
available for a given product. Therefore suppliers may be able to respond to order requests more
quickly if the order quantities are smaller.
5 Data Analysis
This section discusses sources of data, data cleaning, and the application of that data in a
spreadsheet that uses forecasting and inventory policies to allow the user to compare various
inventory options. This section also discusses the storage capabilities of the central warehouse,
as well as a new PIH warehouse in St. Marc.
5.1 Data Sources and Data Accuracy
The main source of data available for our thesis was PIH's online Electronic Medical
Records (EMR) system. It is a restricted access system that we were granted use of for the length
of our thesis research. The EMR system provides monthly consumption data of all products at
each PIH site from December 2001 through the present. For our thesis, we used data from
January 2007 to December 2009. While the EMR system had the capability to export to Excel,
the exported data was not "clean".
Before analysis could begin, significant data organization and cleaning was undertaken.
Historical demand was gathered from the organization's EMR website, while product details and
procurement expenses were collected from previous invoices. Demand is measured as the
amount requested from the Cange warehouse by the individual clinics.
Data organization was conducted in Microsoft Excel and STATA, a statistical software
program. Since PIH has used over 600 products, our analysis only includes items which had
demand of at least 250 units in 2009 in order to reduce complexity. We created programs in
STATA to automatically eliminate products with insufficient demand and to generate historical
demand statistics.
To assess data accuracy we graphed the monthly demand of each product over the past
two years. We grouped the charts peak monthly demand so that comparable scales were used
across products. The chart analysis revealed which products contained data outliers, each of
which we investigated. The charts also revealed that demand is not constant throughout the year,
which supports our assumption that demand is seasonal (Figure 4). We therefore chose a demand
forecasting model that incorporates seasonality.
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Figure 4: Historical Demand by Product
In some instances, it was obvious that the data was mistakenly placed in an adjacent cell.
In these cases, we moved the data to the appropriate cell (Table 3). Other times, outliers were
due to changes in availability of similar products with different strengths or sizes for a short
period. For example, a surge in consumption of 10mg amoxicillin corresponds with a large drop
in 5mg amoxicillin usage. Table 4 shows an example in which similar sized gloves were
substituted.
Table 3: Data for Efavirenz 200mg and Didanosine 200mg switched in March 2008
Type Product
EyeCare TetracyclineHydrochloridel%5gOther
TimololeyedropsO.25%10mlOther
TropicamideeyedropsO.5%10mlOther
AZT+3TC300/1501tabTablet
Abacavir300mgTablet
D4T+3TC+NVP(Triomune-40390mgTablet
Didanosine50mgTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
lndinavir400mgTablet
Lamivudinel50mgTablet
Aug-07 Nov-07 Dec-07 Jan-08 Feb-08 Mar-08
360 800 374 272 211 241
181 4 4 1 7 65
10 0 0 0 0 0
54523 46681 50623 62597 64480 72266
12 0 0 0 22 60
0 0 0 0 0 0
0 0 0 0 0 0
0 0 120 0 60 2110
2040 1290 1778 1590 2161 60
21571 20205 13455 21736 22324 24086
4320 5940 2482 5760 4680 3438
50831 61454 48748 60083 61275 67292
Apr-08
345
6
0
67342
90
0
0
60
2251
21897
4210
57431
May-08
248
16
0
62832
80
0
0
0
3062
22451
4500
63241
Table 4: Size 7 gloves used as a substitute for size 7
Type Product May-09 Jun-09
SOP SurgicalGloves-sterile6(size)Other 0 0
SOP SurgicalGloves-sterile6.5(size)Other 2 0
SOP SurgicalGloves-sterile7(size)Other 446 450
SOP SurgicalGloves-sterile7.5(size)Other 2838 3568
SOP SurgicalGloves-sterile8(size)Other 1741 1367
SOP SurgicalGloves-sterile8.5(size)Other 0 0
.5 gloves in November and
Jul-09 Aug-09 Sep-09 Oct-09
0 0 0 0
0 0 0 57
126 175 449 677
3228 3994 2503 1513
1032 1188 1541 3314
0 0 0 11
December
Nov-09 Dec-09
0 0
144 0
2020 1489
285 56
2040 694
139 0
Two other measures were taken to ensure data accuracy. First, we compared PIH's
weekly consumption data against the monthly consumption data as weekly consumption and
monthly consumption are contained in separate databases in the EMR system. When the weekly
consumption numbers were aggregated, they equaled the data contained in the monthly
consumption database, revealing consistency between the databases. Furthermore, we checked
consumption figures from each of the clinics denoted in the EMR system against PIH's
aggregate consumption database. We manually aggregated consumption from the individual
clinics and found that these data match the data from PIH's aggregate database.
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
........... . ...
To conduct our data analysis, we linked the product detail database that we created,
which includes weight, volume and price, to the historical demand database in order to have an
integrated system. Product names across different PIH databases were not similar. For this
reason, we created a unique name that is used across all sections of the model. We also created a
document that shows a product's unique name, along with the original name used in each
database. Having unique names is important so that PIH can efficiently import new demand data
to update inventory policies.
5.2 Using the Spreadsheet Model
Our forecasting and inventory policy models were created in Microsoft Excel. The
models include includes macros so that projected demand, inventory policies and simulation
outputs are automatically generated. In order to tabulate new projections and policies for each
product, the user of the model only needs to update historical data. The user can also specify
certain parameters such as lead time (L), number of months between orders (R), order-up-to
levels (S), and k. The user can also alter parameters, alpha, beta and gamma, in the demand
forecasting model to make the model more or less sensitive to recent demand or seasonal effects.
Below is a detailed overview of each of the 29 tabs in the spreadsheet model. Each tab falls
under one of five categories: Product Data, Forecasting, Inventory Policies, Simulation Results
and Warehouse.
In the following pages, product tabs are described in the order they appear from left to
right in the spreadsheet. The last four tabs address the Cange warehouse area and available
volume for storage of goods. Only the upper level of the Cange warehouse is considered for
storage space. Furthermore, the appendix includes snapshots of tabs that do not have snapshots in
this section.
Table 5: Overview and Description of Tabs in the Model
Category Tab Description
Product Data Product Details Weight, volume, price of products
Product Data Monthly Data Historical product demand
Product Data Clean Monthly Data Cleaned version of historical demand
Forecasting ForecastModel Generates forecasted demand for a given product
Forecasting ForecastOutput Forecasted demand over 3 years for each product
Forecasting CleanForecastOutput Cleaned version of forecasted demand
Inventory Policies Parameters User sets key parameters such as L, R, k, and B2
Inventory Policies Reorder Point Inventory level at which a new order is placed
Inventory Policies Order up to Level Quantity ordered = S - Inventory Position
Inventory Policies Simulated Demand Demand simulations for each product
Inventory Position Physical Stock - Monthly Orders Inventory of each product at the warehouse
Inventory Position Emergency - Monthly Orders Monthly emergency purchases for each product
Inventory Position Physical Stock -Annual Orders Inventory of each product at the warehouse with annual orders
Inventory Position Emergency - Annual Orders Monthly emergency purchases for each product with annual orders
Inventory Position Orders Monthly orders for each product
Inventory Position Order Arrival Monthly arrivals of ordered products at the warehouse
Inventory Position Container Arrival Number of containers that arrive at Port au Prince each month
Inventory Position In Transit Stock Monthly inventory of in-transit products
Inventory Position Physical + In Transit Stock Total inventory position
Inventory Position Volume Reqs - Monthly Orders Volume of inventory in warehouse each month
Inventory Position Volume Reqs - Annual Orders Volume of inventory in warehouse each month under an annual order policy
Simulation Results Emergency Procurement Sims Simulation results from each inventory policy for emergency procurement costs
Simulation Results Volume Sims Simulation results from each inventory policy for volume of warehouse inventory
Simulation Results Container Arrival Sims Simulation results from each inventory policy for container arrivals
Simulation Results Charts Charts of simulation results
Warehouse Cange Warehouse Layout Warehouse wall lengths
Warehouse Cange Shelf Storage Determines available volume of shelves
Warehouse Cange Available Floor Space Determines available floor space
Warehouse % Goods Cange Percentage of goods that remain in the Cange medical complex
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10 AmpicillmlgOther 1500
11 AtenololSOmgTablet 360
12 Penici0mBenzahine2 4kMuAmpullA 566
13 Acidbenzoic6%+Acidshiclic3%40mgOther 30
14 BenzyPenicimt5MuAmpulle 100
15 CalciumGluconate10%1(rtem)Ampuile 50
16 Captopno25mgTablet 2000
17 Carbmnazepne200mgTablet 266
18 Cephalex 500mgTabet Too
19 cebnaxonelgAmpulle 4000
20 CNoramphenicol1gOther 250
21 cloroqume(50mg/ml)60mlottle 40
22 chloNoqune15mgTablet 480
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o 00000167 0.0010007 001
000000062 000061538 040
0 00000100 00006 0 15
00000600 0.0056 0.28
0.00042151 0.01686038 22.34
0.00000256 0.00255946 9.47
0 00001560 0.00078 0-78
0.00006667 6.6667E-05 0 01
0 00005573 0.00270067 4 18
0.00000066 0.00065714 023
0.00005627 0.00276364 1 52
0.00021714 0.00217143 0-76
0.00000800 0.0043 0.43
0.00005000 0001 0.00
000000120 0.00012 0,24
000000120 00012 030
0 00000243 000024286 0 17
000008200 000082 3.28
0.00004160 0.00208 0.52
0.00017821 0.03475 139
0.00000152 0.00152083 0.73
0.00000050 0.0005 0.01
0.00000444 0.000444 4.44
0.00000680 0.00008 0.17
0.00013750 00001375 0.55
000000327 0.00163333 735
0,00166667
0.00 0.00061538
0.05 00006
0.04 0.0066
0,01686038
4.91 0,00255946
0.00078
6.6667E45
2.11 0.00278667
0,06 0,00066714
028 0.00276364
0.19 0.00217143
0.0043
0.001
0,67 000012
0.10 0.0012
0 10 0 00024286
2.36 0.0002
0.00200
194 0.03475
0.37 0.00152083
0.0006
2.22 0.000444
015 0.00068
00001375
3.06 0-00163333
1000 ,000
1000 660.000
500 150.000
100 5.000
40 53,000
1000 3700000
s0 50,000
1 150
50 75,000
1000 350,000
50 27,500
10 3,500
50 5,000
20 1,000
100 200,000
1000 250,000
100 70,000
10 40.000
50 12.500
195 7,800
1000 480,000
1000 20.000
100 1000000
100 25,000
1 4.000
500 2,250,000
Unit Price/Qu
Price antilt Total Cost DemandD9
002003 12018
000195 1.26750
0.02498 3,747,00
04417 2.208.50
048325 25.612.20
0.0336 124,32000
0.1744 8.72000
11.61 1,72650
0-247 1852500
0.00642 2,24700
0,8612 23,68300
0.405 1A17.50
0.8668 4334.00
0.213 213.00
0.0126 2.520.00
001382 3455.00
0.1068 7476.000.789 31,560.00
04062 5.077,50
0669026 4,43840
0.01124 5,395.20
0.00516 103.20
0.040 40,50000
0.388 9,700.00
0.4 1,600.00
002456 55.260.00
4.820
45.694
792
1,918.142
37,813
91,520
0,066
887
557,240
02,000
43.009i
28.740'
10,897
244,883
499.267
6,736
936,049
2003
195
12 49
44 17
19.33
336
872
11 51
1235
6.42
43.06
4.05
43.34
426
126
1382
1068
7,89
20,31
11096
1124
5 16
4.06
388
0.4
12.20
Figure 5: Snapshot of Spreadsheet Model and Tabs
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Product Details Tab
This tab contains the unique name, volume, weight and price for each product. The data
were collected from PIH's order invoices from IDA and PIH's Google Tracker site, and was
entered manually. Other sections of the model draw volume and price data from this tab to
calculate stockout costs and volume requirements.
The product details tab also includes a column calculating the ratio of 2009 annual
demand to actual order quantity placed by PIH. Although the ratio averages 78%, it varies
significantly across products (Figure 6). For some products the ratio is 1%, while it is above
700% for others. A notably low ratio signifies that PIH will have insufficient supply and will
incur stockouts and be subsequently forced to place emergency orders for drugs and supplies. A
ratio well above 100%, on the other hand, reveals that PIH will have excess inventory and less
warehouse space for other items. PIH currently determines order quantity qualitatively through
talks with staff in Haiti. Our analysis, however, reveals the importance of quantitative demand
forecasting. PIH need not blindly follow our demand forecasts, but it can use them as a base
estimate which can then be altered based on the projections of staff in Haiti.
We were unable to obtain volume data for 90 of the 307 products studied in our analysis.
Therefore, the inventory volume and emergency procurement costs data produced by the model
are underestimates.
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Figure 6: Annual Demand vs PIH'S Annual Order
Monthly Data Tab
The Monthly Data tab includes historical monthly demand for each product from January
2007 to December 2009. The data were all gathered from PIH's EMR website under the
"Monthly Consumption Report" link. The months run horizontally and products are organized
vertically by type of product, such as Eye Care, HIV and Injectables. PIH can update this tab
with new demand data to adjust demand forecasts. The tab also includes summary statistics such
as annual demand and maximum monthly demand. It should be noted that there may be accuracy
concerns with the data. PIH's clinics in Haiti often lack internet access, so consumption figures
are not always entered in the EMR system on a regular basis.
Clean Monthly Data Tab
The demand forecast model does not run properly for products that have no demand over
a four month period. Therefore, we created the Clean Monthly Data tab, which automatically
replaces each monthly demand value of zero from the Monthly Data tab with a value of one.
Cumulatively the replacement of zeros with ones increases historical demand by 0.003%. For the
ten products most impacted by this adjustment, the range of increased historical demand is 5.7%
- 12.5%. If demand for a given month is greater than zero, this tab simply imports the value from
the Clean Monthly Data tab. Figures 7 and 8 below show how this tab updates the Monthly Data
tab for values of zero. Other sections of the model use this historical demand data to forecast
product demand.
type product JanQI Feb-07 Mar-07 ynZ day7 Junm07 hJIJLQZ A gQI da:QZ Qg
EyeCare Gentamycineeyedrops0.3%l0mOther 503 271 222 381 253 392 323 143 108 288
EyeCare TetracychneHydrochloridel%SgOther 208 65 106 193 491 282 127 360 490 640
EyeCare Tirnololeyedrops0.25%l0mlOther 131 50 15 59 141 9 109 181 23 102
HIV Abacair300mgTablet 10 30 34 90 21 20 20 12 20 20
HIV AZT+3TC300/1501tabTablet 46282 41711 42208 56599 55895 55423 65904 54523 56504 67737
HIV Didanosine200mgTablet 0 60 120 120 0 60 120 0 60 0
HIV Efavirenz200mgTablet 2004 1530 2130 1828 1911 1451 2010 2040 1920 1560
HIV Efavirenz600mgTabet 17245 16518 16013 21398 18336 19074 20949 21571 18974 23819
HIV Indinair400mgTablet 5040 4320 3060 4320 3960 5220 4500 4320 3966 4726
HIV Lamivudine150mgTablet 61999 56641 56742 72405 53787 52616 61592 50831 56632 61813
Figure 7: Monthly Data (Original Data)
b= proct :Z EbhQZ Mar0 6t:QZ May-7 d:Z "ykQZ Aug:QZ Se"Q .QstZ
EyeCare Gentamycineeyedrops0.3%10mlOther 503 271 222 381 253 392 323 143 108 288
EyeCare TetracyckneHydrochloride1%5gOther 208 65 106 193 491 282 127 360 490 640
EyeCare Timoloeyedrops0.25%10rdOther 131 50 15 59 141 9 109 181 23 102
HIV Abacair300mgTablet 10 30 34 90 21 20 20 12 20 20
HIV AZT+3TC300/1501tabTablet 46282 41711 42208 56599 55895 55423 65904 54523 56504 67737
HIV Didanosine200mgTablet 1 60 120 120 1 60 120 1 60 1
IV Efairenz200mgTablet 2004 1530 2130 1828 1911 1451 2010 2040 1920 1560
HIV Efavirenz600mgTabet 17245 16518 16013 21398 18336 19074 20949 21571 18974 23819
HIV ndinavir400mgTablet 5040 4320 3060 4320 3960 5220 4500 4320 3966 4726
HIV LamMidine150mgTabet 61999 56641 56742 72405 53787 52616 61592 50831 56632 61813
Figure 8: Clean Monthly Data (Replaces Values of Zero with One)
Forecast Model Tab
This tab generates forecasted demand for each product over a two year horizon. The
methodology used is the same as described in the "Demand Forecasting" component of the
Methods section earlier in this paper. We created a "Forecast" macro that automatically imports
monthly data from 2007 - 2009 into this tab, with each product being imported separately. There
are columns for the moving average of demand, seasonality factor (F), level demand (a) and the
trend of demand over time (b). The model also incorporates more recent data to renormalize F.
............
Output appears in the "Forecast(t)" column at the right side of the model (Figure 9). This column
displays the monthly forecasted demand for a given product. Once demand has been forecasted
for a product, the macro imports historical demand from the "Clean Monthly Data" tab for the
next product.
The user can also adjust the values for alpha, beta and gamma. Alpha determines how
sensitive the level of demand is to recent data, beta determines the sensitivity of demand trends
to recent data, and gamma determines the sensitivity of F to recent data. The forecast runs from
February 2010 to December 2012 and the duration of the forecast can easily be increased by
copying the "Forecast(t)" column (column Q) to cells further down.
I Mnth Defmand Fest ft+1
-23 Jan-07 1 1.0
-22 Feb-07 1 10
-21 Mar-07 1 10
-20 Apr-07 1 10
-19 May-07 1 1.0
-18 Jun-07 1 1-0
-17 Jul-07 1 1.0
-16 Aug-07 1 1.0
-15 Sep-07 1 1 0
-14 Oct-07 1 1,0
-13 Nov-07 1 1.0
-12 Dec-07 1 1-0
-11 Jan-08 1 1.0
-10 Feb-08 1 1 0
-9 Mar-08 1 10
-8 Apr-08 1 1.0
-7 May-08 1 1 1
-6 Jun-08 1 1+3
-5 Jul-08 5 18
-4 Aug-08 1 2.9
-3 Sep-08 19 4 0
-2 Oct-08 8 53
-1 Nov-08 11 61
0 Dec-08 8 6-3
1 Jan-09 3 7.1
2 Feb-09 7 8.8
3 Mar-09 36 12.2
4 Apr-09 33 17.3
5 May-09 58 230
6 Jun-09 52 284
7 Jul-09 58 32.4
8 Aug-09 42 34.1
9 Sep-09 36 33.2
10 Oct-09 4 31,0
11 Nov-09 15 286
12 Dec-09 29 268
1 Jan-10
2 Feb-10
3 Mar-10
4 Apr-10
5 May-10
6 Jun-10
7 Jul-10
8 Aug-10
9 Sep-10
10 Oct-10
11 Nov-10
12 Dec-10
13 Jan-11
14 Feb-11
15 Mar-11
16 Apr-11
17 May-11
18 Jun-11
19 Jul-11
20 Aug-11
21 Sep-11
22 Oct-11
23 Nov-11
24 Dec-11
25 Jan-12
26 Feb-12
27 Mar-12
28 Apr-12
29 May-12
30 Jun-12
31 Jul-12
32 Aug-12
33 Sep-12
34 Oct-12
35 Nov-12
36 Dec-12
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1.0
10
10
1,0
1,0
10
1.0
1.0
10
1.0
1.0
10
1.0
10
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29
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5-3
6.1
63
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8.8
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23 0
284
324
34-1
332
31 0
286
1.00
1.00
1 00
1 00
1 00
1.00
0.86
0.75
0,48
0 32
0 39
0-44
0.86
1.40
130
110
071
0.41
0.46
0.63
0.92
134
1,63
1 71
21.71
E Estimate X t
0.73 14
076 13
0.78 1.3
0,92 1 1
1.12 0.9
119 0,8
103 10
1.33 08
127 08
116 09
0.95 1+1
0.78 1.3
073 1.4
0.76 1,3
0.78 13
0.92 11
1,12 13
119 17
103 41
1.33 5.6
1-27 7-1
1.16 92
0.95 1lL
078 9.4
0.73 141
0.76 21 5
0.78 340
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Figure 9: Forecast Model
Forecast Output Tab
The "Forecast" macro automatically imports the data from the "Forecast(t)" column in
the "Forecast Model" tab into the "Forecast Output" tab. The layout of this tab is similar to that
of the "Monthly Data" tab with months running horizontally and products running vertically
organized by type. The tab contains the demand forecasts for each product.
Clean Forecast Output Tab
Forecasted demand is negative for some products for which demand decreases over time.
This forecast of negative demand is a problem for two reasons. First, actual demand for a product
cannot be less zero. Second, the inventory policy model is thrown off by negative values,
specifically when calculating inventory volume. Therefore this tab changes negative values in
the "Forecast Output" tab to zero (Figures 10 and 11).
y= Product Feb-10 Mar-10 Ap-1 May-10 Jun-10 ju:1 Aug10
EyeCare Gentamycineeyedrops0.3%10mlOther 160 174 197 234 247 225 208
EyeCare TetracyclineHydrochloridel%5gOther 244 253 299 346 320 299 320
EyeCare Timololeyedrops0.25%10mlOther 40 40 36 38 52 59 59
HIV Abacavir300mgTablet 461 620 762 856 852 646 636
HIV AZT+3TC300/1501tabTablet 105,361 110,128 117,311 122,931 127,936 127,622 127,743
HIV Didanosine200mglabiet 56 49 45 44 69 80 80
HV Efavirenz200mgTablet 5,352 4,417 2,345 1,045 2,319 3,280 3,243
HIV Efavirenz600mgTablet 38,685 41,470 46,364 49,921 51,692 49,588 48,777
HIV Indinavir400mgTablet 4,229 4,270 4,180 4,242 4,509 4,531 4,414
HIV Lamivudinel50mgTablet 114,320 109,801 109,583 112,356 116,608 111,266 109,488
HfV LamivudineSuspensionl0mg/l0m240mlBottle 98 111 120 120 123 97 76
HIV Lopinavir/Ritonavir250mgTablet 15,978 16,373 17,022 17,039 17,535 8,754 9,636
HIV Nevirapine200mgTablet 115,468 118,465 122,331 125,438 127,362 125,891 126,220
HIV Nevirapinesusp50mg/5ml24OmIBottle 34 32 35 38 39 37 35
HIV Stavudine30mngCapsule 105,205 111,996 126,096 147,920 178,345 196,959 211,302
HIV Stavudine40mgTablet -1,531 -3,450 -6,780 -13,756 -13,256 -15,066 -12,225
HIV Tenofovir300mgTablet 2,596 2,634 2,755 2,848 3,093 3,016 2,923
HIV Zidovudine300mgCapsule 12,089 7,637 6,420 7,491 4,871 3,487 4,670
HIV Zidovudinesuspension200mlBottle 145 168 191 201 217 190 144
Figure 10: Original Forecast Output
Iyeg=
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EyeCare
EyeCare
HIV
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HIV
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HIV
HIV
HIV
HIV
HIV
HIV
HIV
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HIV
HIV
Product
Gentamycineeyedrops0.3%0mlOther
TetracyclineHydrochloridel%5gOther
Timololeyedrops0.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudinel50mgTablet
LamivudineSuspensionl0rrg/0ml240mlBottle
Lopinavir/Ritonavir250mgTablet
Nevirapine200mrngTablet
Nevirapinesusp50mg/5ml240mlBottle
Stavudine30mgCapsule
Stavudine40mgTablet
Tenofovir300mgTablet
Zidovudine300mgCapsule
Zidovudinesuspension200mlBottle
Figure 11:
Parameters Tab
The "Parameters" tab contains the user-set parameters for inventory policies. The
parameters, which are highlighted in yellow in the model, include stockout penalty percentage
(B2), k for A-items and B-items, lead time in terms of months (L), review period in terms of
months (R), and the ratio of S/s (Figure 12). Items were determined as A-items or B-items based
on directions from PIH, who referred us to the Daily Report the EMR system compiled for each
site. PIH considers the products tracked in this Daily Report to be "essential" items of which
they cannot stock out.
If R = 1, orders will be placed every month that the inventory position is below the
reorder point. If R = 3 orders will be only placed quarterly. Although the default for R is 1, PIH
can adjust this value if monthly orders are too cumbersome. An increase in k will lead to an
increase in safety stock and inventory volume, but a reduction in emergency purchases. PIH can
also adjust B2 from the default value of 50% if emergency procurement markups deviate from
this average.
Feb-10 Mar-10 Ap-0
160 174 197
244 253 299
40 40 36
461 620 762
105,361 110,128 117,311
56 49 45
5,352 4,417 2,345
38,685 41,470 46,364
4,229 4,270 4,180
114,320 109,801 109,583
98 111 120
15,978 16,373 17,022
115,468 118,465 122,331
34 32 35
105,205 111,996 126,096
0 0 0
2,596 2,634 2,755
12,089 7,637 6,420
145 168 191
Clean Forecast Output
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Actual stockout figures, inventory volume and total emergency procurement costs are
calculated automatically in the "Parameters" tab. Further down in the sheet are k values, standard
deviations of demand, safety stocks, purchase costs, transportation costs and unit sizes for each
product. For products for which we lack unit sizes, we assume 100 individual items per unit.
This tab also includes parameters for inventory holding costs (r), order cost (A), shipping
costs, and the volume of a shipping container. The inputs can be adjusted if PIH wants to see
additional financial implications of inventory policies and the number of containers required per
shipment.
r 015
A (total) 200
Number products/order 100
Shipping Cost/m3 133.60
Container Volume (m3) 55
Stockout Penalty/Markup (B2) 50%
k: A-items 2.33
k: B-items 1.65
Stockout % A-items 0.816%
Stockout % B-items 2.929%
Average Volume 84.0
Lead Time (months) 4
Review Period (months) 1
L+R 5.0
Order-up-to/Reorder Point (S/s) 1.0
Annual Emergency Procurement Costs $4,936
Average Containers/Month
Safv stock AcuaL im
t B~ul rdPro ck) -g14 AwIsodo vpoduct) vrsp M21La) A UnitSiz UnitSize
EyeCare Gentamycineeyedrops0 3%10B 1 65 1.65 140 0 15 516 0.425 0.008016 0433016 2 100 100
EyeCare TetracyclineHydrochloridel%EB 165 1.65 153 0.15 563 02568 0.005961 0.262761 2 50 50
EyeCare Timololeyedrops0.25%10mOt B 1+65 1.65 46 0.15 170 1.88 0002672 1.882672 2 1 1
Figure 12: Parameters Tab (Inputs Highlighted In Yellow)
Reorder Point Tab
This tab automatically calculates every product's monthly reorder point, or s. As
discussed previously s = X(L+R)± k*c(L+R) and changes monthly because forecasted demand
changes over time. The formula for reorder points in the model is lengthy since s is dependent
upon the values of L and R. Longer lead times and review periods mean that s incorporates more
months of forecasted demand and thus requires several "if' statements in Excel. Whenever
product inventory falls below the respective s in a review period, a new order is placed
automatically in the "Orders" tab.
Order up to Level Tab
The formula to determine S is simple. It is merely the S/s ratio, defined by the user in the
"Parameters" tab, multiplied by the relevant month's s. Since S is determined by s, there is a
different value for each month and each product. Data from this tab is used to calculate the order
quantity.
Simulated Demand Tab
If the model used the exact forecasted demand numbers in consumption simulations,
there would never be a stockout since s and S are based on forecasted demand plus a safety stock
component. Therefore we use simulated demand in our simulations to test the robustness of
inventory policies on inventory volume, emergency procurement costs and other benchmarks.
We created a "Simulations" macro that automatically generates random numbers from 0
to 1 at the bottom of the "Simulated Demand" tab. A unique random number assigned to each
product and each month. The tab incorporates these random numbers to calculate simulated
monthly demand for each product via the excel function MAX(NORMINV(Random number,
Forecasted demand, Standard deviation of demand),0). Since the formula for simulated demand
can generate negative values, we use the max of zero or the simulated demand for each month.
This function assumes that demand follows a normal distribution. The table below shows that
demand for the drug AZT and plastic pipettes are distributed normally since the chi-square value
is well below the threshold of 9.49, assuming four degrees of freedom, for rejecting the null
hypothesis that demand is distributed normally.
Table 6: Chi-Square Tests to Assess Normalcy of AZT and Plastic Pipette Demand
Bin Frequency Expected Freq X2 Bin Frequency Expected Freq X2
40000 1 2.32 0.75 2000 4 3.46 0.09
60000 10 8.35 0.33 4000 10 10.52 0.03
80000 14 13.56 0.01 6000 15 13.72 0.12
100000 8 9.03 0.12 8000 5 6.88 0.51
120000 3 2.45 0.12 10000 2 1.32 0.35
1.33 1.10
Physical Stock - Monthly Orders Tab
This tab calculates the number of items for each product that are physically in the
warehouse for each month. The physical inventory is equal to the previous month's inventory -
simulated demand for the month + orders arriving at the warehouse at the beginning of the
month. Since simulated demand differs from forecasted demand, inventory levels occasionally
drop below zero, signifying a stockout (Figure 13). Columns AM-AP of the tab shows the
minimum inventory level over the two years, the number of stockouts, the CSL and cumulative
shortage for each product. These numbers are summarized in the "Parameters" tab.
TyP_ Product 2/28/2010 3/31/2010 4/30/2010 5/31/2010 6130/2010 7/31/2010 8/31/2010
EyeCare Geritamycineeyedrops0.3%10mlOther 1,543 1,413 1,120 793 793 2,304 2,195
EyeCare TetracyclineHydrochloridel%5g~ther 1,935 1,891 1,693 1,241 981 3,356 2,983
EyeCare Timololeyedrops0.25%10mlOther 408 295 261 197 136 582 546
HIV Abacavir300mgTablet 3,455 2,542 1,682 989 162 4,891 4,423
HIV AZT+3TC300/1501tabTablet 604,499 518,754 384,826 276,728 162,098 860,553 713,263
HIV Didanosine200mgTablet 498 409 253 172 105 658 543
HIV Efavirenz200mgTablet 61,838 61,838 61,838 52,557 52,557 128,298 121,991
HIV Efavirenz600mgTablet 222,955 189,376 165,189 121,313 76,559 385,357 326,524
HIV Indinavir400mgTablet 23,417 19,268 15,256 11,100 6,834 31,311 27,400
HIV Lamivudine150mgTablet 563,575 465,213 365,668 243,502 96,360 779,167 675,589
HIV LamivudineSuspension1Omg/lOml240mlB 572 460 354 224 130 787 704
HIV Lopinavir/Ritonavir250mgTablet 79,694 60,965 38,892 21,711 221 92,037 78,026
HIV Nevirapine200mgTablet 623,584 550,992 448,770 293,782 188,401 902,509 752,190
HV Nevirapinesusp5Omg/5nI240mlBottle 192 158 113 81 63 326 299
HIV Stavudine30mgCapsule 733,825 605,093 517,809 377,261 197,563 1,108,094 866,690
HIV Stavudine40mgTablet 122,219 84,127 23,854 -20,207 -20,207 173,993 173,993
HIV Tenofovir300mgTablet 13,391 9,957 5,827 2,099 -1,745 15,681 13,256
HIV Zidovudine300mgCapsule 62,112 58,080 52,413 52,413 35,710 104,810 104,810
HIV Zidovudinesuspension200mlBottle 1,055 836 673 443 165 1,344 1,268
Figure 13: Physical Stock - Monthly (Stockouts Highlighted in Yellow)
Emergency - Monthly Orders Tab
This tab calculates the amount of emergency purchases in the event of a stockout. If there
is a negative inventory for any product in the warehouse, an emergency purchase is
automatically placed. The magnitude of the emergency purchase is only intended to cover an
inventory shortfall for the given month, so that it does not augment any in-transit inventory. The
right side of the tab shows the cumulative amount of emergency purchases and the emergency
procurement costs for each product. The emergency procurement costs are the penalty or markup
over the normal purchase price and are equal to purchase quantity*purchase price*B2.
Physical Stock - Annual Orders Tab
This tab reveals the physical inventory level of each product under an annual order
system and was created to compare the inventory volume and emergency procurement costs
associated with monthly and annual orders. A month's inventory position equals the prior
month's inventory - simulated demand + emergency purchases. Each January, an annual
........... ... ......
shipment of each product arrives at the warehouse. The magnitude of this shipment is equal to
forecasted annual demand + annual safety stock - current inventory position.
Emergency -Annual Orders Tab
This tab is similar to the "Emergency - Monthly Orders" tab, but the size of the
emergency purchase is different. Here, the order quantity is equal to the shortage + S * ((months
remaining in the year) / (L+R)). For example, if a product has a shortfall of 300 in October the
emergency purchase will be 300 + S*2 / (L+R) since there are two months until the next
shipment arrives in January.
Orders Tab
This tab determines when product orders are placed and is thus crucial in minimizing
stockouts and excess inventory. If the sum of inventory in the warehouse plus the in-transit
inventory is less than the current month's reorder point, an order is made. The size of the order is
equal to S - inventory position. Furthermore, the order size must be a multiple of the unit size for
a given product. The model accomplishes this by rounding up the order quantity to the nearest
multiple of the unit size. The model is also set up so that orders can only be placed if the number
of the current month is a multiple of R.
Order Arrival Tab
The "Order Arrival" tab calculates when a shipment will arrive in PIH's warehouse. Lead
times and order date are used to determine when the order will actually arrive. For example, with
a lead time of 4 months an order placed in June will arrive in October. The model is able to
automatically calculate the arrival time through a series of "If' statements in Excel. Figures 14
and 15 below assume L = 4 and illustrate how the "Orders" and "Order Arrival" tabs interact.
My Product 3/1/2010 4/1/2010 5/11/2010 6/1/2010 7/1/2010 8/1/2010
EyeCare Gentamycineeyedrops0.3%10mlOther 300 400 200 100 300
EyeCare TetracyclineHydrochloridel%5gOther 200 500 500 500 150
EyeCare TimololeyedropsO.25%10mlOther 49 125 136 0 72
HIV Abacavir300mgTablet 800 400 400 400 200
HIV AZT+3TC300/1501tabTablet 146,000 102,000 118,900 136,600 85,400
HIV Didanosine200mgTablet 100 100 0 0 100
HIV Efavirenz200mgTablet 16,900 9,600 1,800 700 500
HIV Efavirenz600mgTablet 51,000 37,300 46,400 51,200 38,200
HIV Indinavir400mgTablet 4,300 3,800 3,600 3,000 4,600
HV Lamivudine150mgTablet 147,900 105,000 98,400 120,000 152,900
HIV LamivudineSuspensionl0mg/l0m240mBo 200 0 200 0 100
HIV Lopinavir/Ritonavir25OmgTablet 6,900 13,400 16,400 14,300 19,900
HIV Nevirapine200mgTablet 139,500 117,800 110,200 102,800 136,800
HIV Nevirapinesusp50mg/5ml240mlBottle 100 100 0 0 100
HIV Stavudine30mgCapsule 213,400 100,200 37,400 106,600 84,500
Figure 14: Orders Tab
IyM Product 3/1/2010 4/1/2010 5/1/2010 6/1/2010 7/1/2010 8/1/2010
EyeCare Gentamycineeyedrops0.3%lOlOther 0 0 0 0 300
EyeCare TetracyclineHydrochloridel%5gOther 0 0 0 0 200
EyeCare Timofoleyedrops0.25%l0mOther 0 0 0 0 49
IV Abacavir300mgTablet 0 0 0 0 800
HIV AZT+3TC300/1501tabTablet 0 0 0 0 146,000
HIV Didanosine200mgTablet 0 0 0 0 100
HIV Efavirenz200mgTablet 0 0 0 0 16,900
HIV Efavirenz600mgTablet 0 0 0 0 51,000
HIV Indinar400mgTablet 0 0 0 0 4,300
HIV Lamivudine150mgTablet 0 0 0 0 147,900
IVF LamivudineSuspensionlOmg/lOm240mlBo 0 0 0 0 200
HIV Lopinavir/Ritonavir250mgTablet 0 0 0 0 6,900
HIV Nevirapine200mgTablet 0 0 0 0 139,500
HIV Nevirapinesusp50mg/5ml240mlBottle 0 0 0 0 100
HIV Stavudine30mgCapsule 0 0 0 0 213,400
Figure 15: Order Arrival tab
Container Arrival Tab
The "Container Arrival" tab calculates the projected number of containers that will arrive
at Port au Prince every month. First, the tab calculates the volume of each product arriving at the
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port for a given month. The number of containers is equal to the sum of the arriving order
volume divided by 55 m3, an approximate usable amount of available space in a shipping
container. This tab does not include the volume of products for which we do not have volume
data.
In-Transit Stock Tab
The "In-Transit Stock" tab measures the inventory that has been ordered, but not yet
arrived in the warehouse. As mentioned previously, it is important to track this amount to
prevent numerous orders from being placed for the same inventory shortfall. The in-transit
inventory for a month is equal to the previous month's in-transit inventory + new orders - orders
that arrived in the current month.
Physical + In-Transit Stock Tab (Inventory Position)
This tab measures the inventory position by summing the inventory located at the
warehouse and the in-transit inventory. The inventory position is then checked against the
reorder point to determine if a new order should be placed for each product.
Volume Reqs - Monthly Orders Tab
This tab calculates the monthly cumulative volume of the products in the warehouse. It
does this by importing the individual product volume from the "Product Details" tab and
multiplying this number by physical inventory in the "Physical Stock - Monthly Orders" tab.
Since the physical inventory in our model is negative during stockouts, the volume equation is
set up so that the volume cannot be lower than zero.
The top portion of the tab includes the monthly volumes for each product. At the bottom
are the total monthly volumes for each month along with summary statistics on average,
maximum and minimum volume requirements. Below the monthly totals on the spreadsheet are
data regarding storage capacity at the warehouse.
The storage location for that month's volume is shown. Per review of consumption by
site data over the past six months, it was determined that approximately 15.6% of goods were
used in the Cange Sociomedical Complex, while the remainder went to regional sites. The
warehouse is arranged such that goods remaining in the Cange complex are stored on the
shelves, while goods that will be shipped to regional sites are placed on the floor. Therefore, the
volume of goods for shelf storage is approximately 15.6% of the total volume. The remaining
goods are stored on the floor. Based on the available storage volume on the shelves and floor, it
is then calculated whether there is sufficient storage on the shelving and the floor. Instances in
which insufficient space is available are shown as a bold "NO".
It should be noted that products for which there is no individual volume data are not
included in the cumulative volume requirements. Therefore the number presented in this model
should be viewed as an underestimate of true storage requirements.
Volume Reqs - Annual Orders Tab
This tab is similar to the "Volume Reqs - Model Orders" tab but displays cumulative
volume data under an annual order system. Due to the larger quantities associated with annual
orders, we expect this inventory policy to require greater storage capacity, particularly towards
the beginning of the year. Figures 16 and 17 below reveal that the discrepancy between inventory
volumes in a monthly order system versus an annual order system is greatest at the beginning of
the year. Additionally, the figures show that model does not include data for the HIV drug
Abacavir since we do not have individual volumes for this product.
I= Product 2128/2010 3/31/2010 4/30/2010 5/31/2010 6/30/2010 7/31/2010 8/3112010 9/30/2010 10/31/2010 11/30/2010 12/31/2010 1/31/2011
EyeCare Gentamycineeyedrops0 3%10mlOther 0.085433 0.073534 0.05049 0.031793 0.018603 0.010581 0007601 0 028755 0.0407555 0.0422736 0.0573553 0.065005
EyeCare TetracyclineHydrochloridel%5gOther 0.089494 0.080492 0.06282 0.045536 0.028812 0.035266 0.030326 0.032128 0.0371577 0.0492222 0.0434362 0.052261
EyeCare Timololeyedrops0.25%10mlOther 0.007564 0.006932 0.004811 0 002062 0.002062 0.000571 0.001104 0 002903 0.0052935 0.0050349 0.005083 0.005083
HIV Abacavir300mgTablet
Figure 16: Product Volume under a Monthly Order System
T.jp Product 2/28/2010 3/31/2010 4/30/2010 5/31/2010 6/30/2010 7/31/2010 8/31/2010 9/30/2010 10/31/2010 11/30/2010 12/31/2010 1/31/2011
EyeCare Gentamycineeyedrops0 3%10mlOther 0 164275 0 152376 0 129332 0 110635 0 097445 0071424 0.056443 0 053598 0 0535978 00491159 0.0461976 0 09923
EyeCare TetracyclineHydrochloridel%5gOther 0.207217 0 198215 0 180543 0 163259 0 146535 0.144065 0 127972 0 107466 0 0901882 0 079945 0 0674667 0 160053
EyeCare Timololeyedrops0.25%10mlOther 0 015165 0 014533 0 012412 0 009663 0 009663 0.007192 0.006704 0 006004 0-0056741 0.0054156 0,0040237 0 010519
HIV Abacavir300mgTablet
Figure 17: Product Volume under an Annual Order System
Emergency Procurement Sims Tab
The monthly emergency procurement costs for each simulation iteration are placed in this
tab. For each iteration, costs are calculated automatically by the "Simulations" macro for the
seven inventory policy scenarios listed in section 4.3. Since 250 iterations were run, each
inventory policy has 250 lines of data.
Volume Sims Tab
The inventory volumes in the warehouse from each simulation iteration are placed in this
tab. For each iteration, the volume is calculated automatically by the "Simulations" macro for the
seven inventory policies.
Container Arrival Sims Tab
The number of arriving containers from each simulation iteration is placed in this tab. For
each iteration, the number of containers is calculated automatically by the "Simulations" macro
for the seven inventory policies.
Charts Tab
The "Charts" tab provides summary statistics from the "Emergency Procurement Sims",
"Volume Sims" and "Container Arrival Sims" tabs. For these outputs, the mean, fifth percentile
and 95* percentile are automatically calculated under each inventory policy. The tab also
contains charts illustrating the simulation results for these outputs from 2010 through 2012.
Cange Warehouse Tab
This tab allows for the user to enter the length of the Cange warehouse walls. The output
is the total area of the warehouse.
Shelf Storage Tab
This tab allows for entry of shelving length, depth, average aisle width, number of (each
variation) of shelves and the number of rows of shelves. The tab also allows the user to alter
height between shelves, the number of shelves holding boxes, the number of shelves holding
loose goods, and the approximate volume cube used on each shelf. The outputs are total area
required for the shelving footprint, and total available volume of the shelving units.
Available Floor Space Tab
This tab allows for input of the exterior aisle width, entry length and width, back aisle
width and length, AC units length and width, and the maximum box stacking height. The outputs
are the total footprint area available on the warehouse floor, and the total available volume of
goods that can be stacked on the warehouse floor. The total maximum available storage volume
in the warehouse (shelf storage plus floor storage) is also an output.
% Goods Cange Tab
This tab calculates the percentage of goods that remain at the Cange Sociomedical
complex based on historical consumption data. We used the six month period from July 2009 to
December 2009 as the relevant historical period when calculating the percentage of goods that
remain in Cange. An alternative historical window could be chosen, if desired.
5.3 Data Analysis Concerns: Missing Product Volumes
As mentioned previously, volume data for approximately one-third of PIH's products was
unavailable. This makes evaluation of inventory policies in relation to the available storage
volume in the central warehouse difficult.
5.4 Storage Capabilities of the Central Warehouse
The building that houses the central warehouse in Cange consists of two floors (Figure
18). The lower level is used to store equipment, while the upper level contains both office space
and storage space. The storage area on this upper level is used to store the products discussed in
this thesis. A site visit and subsequent measurements of the upper level found the area to be
approximately 185 square meters. This 185 square meters includes a 24 square meter section of
the warehouse devoted to cold stores. Therefore, total floor space available for general storage
was limited to approximately 161 square meters (See Figure 19).
Storage in the warehouse is split between shelving and the floor. A portion of the goods
is stored on plastic shelving. These are goods that will stay on site at the Cange Sociomedical
Complex facility. The remaining goods are stored in their original shipping boxes on the
warehouse floor. Per review of the last six months of consumption data in 2009, about 15.6% of
goods were used within the Cange Sociomedical Complex, and the rest were distributed to
regional sites.
Figure 18: Central Warehouse (Cange)
Source: PIH Picasa Web Albums-ZL
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Shelving Units
Shelving units consist of three or four shelves (Figure 20). The shelves are approximately
0.61 meters (2 feet) deep, with 0.61 meters height between shelves. Each of the shelf units is
placed back to back with another shelf unit, resulting in a total shelf depth of 1.22 m (4 feet).
There are two shelf lengths used: 1.68 meters (66 inches) and 2.44 meters (96 inches). A total of
fourteen 1.68 meter length shelves and eight 2.44 meter length shelves are used in the
warehouse. The lowest shelf is used to store boxes of products. The two (three shelf units) or
three (four shelf units) upper shelves are used to store loose items.
Figure 20: Shelving in the Central Warehouse
Source: PIH Picsa Web Albums-ZL
Shelving Footprint
There are two components to consider for the shelving footprint: the footprint of the
shelves themselves and the footprint of the aisles running between parallel shelves. The footprint
52
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of the shelving in the central warehouse consumes approximately 26 square meters. The footprint
of the aisle between the shelves adds approximately 11 square meters. Therefore, the total
footprint consumed by the shelving and interior aisles is approximately 37 square meters (Figure
21).
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Figure 21: Shelving Footprint, including interior aisles (all dimensions in meters)
Perimeter Aisle Footprint
The footprint of the 0.86 meter (34 inch) aisle that surrounds the perimeter of the
shelving is approximately 27 square meters.
Shelving Available Volume
For the purpose of this thesis, we assumed that the utilization of cube on the box storing
shelves (lowest shelf on each unit) was 80%. This means that 80% of the volumetric space
between the lowest shelf and the shelf above it is used. For the upper shelves that store loose
goods, we assumed that the utilization of cube was 20%. We assumed such a low utilization of
cube for these shelves as when loose goods are stored at the individual level, they are often
small, and use only a small portion of the available volume between shelves. Based on these
assumptions, a total of approximately 32.6 cubic meters is available for storage on the shelving
units.
Shelving Issues
Staff at PIH Boston considers the current shelving system to be less than optimal. The
shelving is plastic, with each shelf consisting of a plastic grid. The opening in the grid pattern is
considerable, and causes loose bottles to sit unevenly. Very small bottles can fall through the
grid unless cardboard or a similar object is laid on the grid first. The shelf height is not flexible,
and therefore cannot be adjusted to suit the storage of the particular items on that shelf.
Floor storage
The remainder, and majority, of goods are stored on the floor of the warehouse, in the
original shipping packages (Figure 22). Most of the goods are stored along the walls of the
warehouse, two boxes deep. If an additional row or two of boxes is desired beyond two deep, an
aisle is formed. The average aisle width between boxes is 0.61 meters (24 inches). To determine
the (maximum) amount of available floor storage space, the following method was used:
Area of warehouse - (area of shelving including aisles) - area of air conditioning unit
footprint - area of entryway - area of back aisle
The area described as "back aisle" refers to theoretical 0.86m wide aisle that would run
the length of the back wall of the warehouse. It represents what would be considered the minimal
amount of aisle spacing needed in order to have adequate access to stacked rows of boxes.
We assumed for the model that boxes were stacked 2.44 meters (8 feet) high. Even with
these generous assumptions for use of floor storage space, it was determined that only 200 cubic
meters of goods can be stored on the floor.
Figure 22: Floor Storage in the Central Warehouse
Source: PIH Picasa Web Albums-ZL
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5.5 The St. Marc Warehouse
A new warehouse (Figures 23, 24) has recently been constructed at the St. Marc hospital
and clinic in the Artibonite region. At approximately 282 square meters (Figure 11), it is the
largest PIH warehouse in Haiti. While the warehouse is already being used for storage, shelving
has yet to be installed. Currently, the warehouse only serves its operations in St. Marc. However,
due to its large size, the warehouse has potential to serve other areas in the Artibonite region.
Figure 23: Exterior of the St. Marc Warehouse (during construction)
Source: PIH Picasa Web Albums-ZL
. . .................. 
. ... ... .... .
Figure 24: Interior of the St. Marc warehouse (during construction)
Source: PIH Picasa Web Albums-ZL
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Figure 25: St. Marc Warehouse Layout
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6 Results
We ran 250 simulations for each of the five scenarios covered in the Methods section of
the paper. Below are the results by metric.
Warehouse Inventory Volume
A review period of one month produces the smallest inventory volume in the warehouse.
Furthermore, the inventory volume of all policies from R=1 to R=6 is significantly lower than
the volume resulting from an annual order system. A decrease in L from four to two also reduces
inventory volume, but the change is relatively small. For example when R=3, a reduction in lead
time from four to two months causes inventory volume to decrease 16%. On the other hand
changing from annual to quarterly orders reduces inventory volume 56% when L=4. Table 7
details the average inventory volume under different inventory policies.
The first chart (Figure 26) illustrates the monthly volume associated with each inventory
policy under one simulation iteration. The second chart (Figure 27) graphs the quantity of
amoxicillin contained in the warehouse over time for each inventory policy. The final chart
(Figure 28) shows the mean, 5th percentile and 9 5th percentile of monthly inventory volumes
from the 250 simulation iterations when L=4 and R=3. As this chart shows, the range of
inventory volumes is narrow in a given month. This finding held for each of the inventory
policies.
Table 7: Average Inventory Volume by Policy from 250 Simulations
Policy Average Volume
L=2,R=1 62
L=2,R=3 125
L=2,R=6 222
L=4,R=1 85
L=4,R=3 147
L=4,R=6 235
Annual 339
Min Volume
36
43
51
42
50
59
66
5% Volume 95% Volume
47 97
62
81
59
72
88
102
201
360
201
292
417
610
Max Volume
160
264
398
264
355
480
673
Warehouse Inventory Volume (M3) by Inventory
Policy under 1 Iteration
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Figure 26: Warehouse Inventory Volumes by Inventory Policy
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Figure 28: Warehouse Inventory Volume with Confidence Bands
Inventory Quanity for Amoxicillin under 1 Iteration
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Figure 27: Quantity of Amoxicillin by Inventory Policy
Warehouse Inventory Volume (m3 ) with Confidence
Bands for L=4, R=3
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Emergency Procurement Costs
In our model emergency procurement costs, are summed over the three years of the
simulation and are volatile over the 250 simulations. The second column in Table 8 shows the
total emergency procurement costs over the three year forecasted period for each inventory
policy. The remaining columns show the summary statistics for monthly emergency procurement
costs. The first chart (Figure 29) shows the monthly emergency procurement costs from one
iteration for each inventory policy. Generally, an increase in R leads to a reduction in emergency
procurement costs. However, there is a tradeoff between emergency procurement costs and
inventory volume (Figure 30). The final chart (Figure 31), which shows the mean, 5th percentile
and 95th percentile of emergency procurement costs from the 250 simulation iterations, reveals
that these costs are much more volatile than inventory volume.
Table 8: Average Emergency Procurement Costs from 250 Simulations
Average Total 5% Total 95% Total Max Total
Emerg Min Total Emerg Emera Emerg Eenrg
Procurement Procurement Procurement Procurement Procurement
Policy Costs Costs Costs Costs Costs
L=2,R=1 $16,956 $8,299 $10,662 $25,469 $36,897
L=2,R=3 $11,233 $4,170 $5,626 $19,288 $33,979
L=2,R=6 $8,647 $2,400 $3,288 $17,513 $30,219
L=4,R=1 $17,554 $7,551 $10,277 $27,534 $42,756
L=4,R=3 $12,005 $3,986 $6,170 $20,989 $32,794
L=4,R=6 $10,809 $2,433 $4,286 $21,450 $41,827
Annual $11,432 $2,454 $4,216 $21,914 $55,028
Total Emergency Procurement Costs by Inventory
Policy under 1 Iteration
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Figure 29: Emergency Procurement Costs by Inventory Policy
Inventory Volume (m3) vs Emergency
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Figure 30: Trade-Off Between Inventory Volume and Emergency Procurement Costs
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Figure 31: Emergency Procurement Costs with Confidence Bands
Container Arrivals
The number of containers arriving annually is fairly constant across all inventory policies
(Table 9). However, the distribution of containers over time is significantly different across
inventory policies (Figure 32). The number of containers remains level over time when R=1. The
curve gets significantly choppier, though, as R increases. Finally, the volatility of the number of
containers is minimal across simulations as illustrated in Figure 33.
Table 9: Annual Containers by Inventory Policy
Average Annual Min Annual 5% Annual 95% Annual
Containers Containers Containers Containers
9.6 9.2 9.4 9.8
9.0 8.6 8.8 9.3
9.5 9.1 9.2 9.7
9.0 8.6 8.8 9.2
9.3 8.9 9.1 9.5
9.4 9.0 9.2 9.6
10.7 10.4 10.5 10.9
Max Annual
Containers
10.0
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7 Additional Factors
7.1 Tracking of Goods
PIH currently performs stock keeping by hand at all sites. Three or four times a year,
each site takes a total inventory. A basic barcode system holds the potential to improve the ease
and accuracy of stock keeping greatly. The use of Radio Frequency Identification (RFID) tags is
another possibility. While RFID tags would provide the least labor intensive way of tracking
goods, it might not be practical as it would not allow goods to be tracked at the individual level.
In addition, the costs of creating an RFID system are very high.
7.2 January 2010 Earthquake
In January 2010, a 7.0 Mw earthquake struck Haiti outside of Port Au Prince. It is
estimated that at leastl 50,000 lives were lost. Fortunately, neither the Sociomedical Complex nor
the regional sites were immediately affected by the quake. However, there will be a permanent
increase in the population served by PIH's catchment areas due to internal migration.
It is expected that 500,000 people will move permanently from Port Au Prince. Prior to
the earthquake, the city's population was estimated to be between 2.5 and 3 million people. It is
expected that a large portion of the population leaving Port au Prince will settle in the Central
Plateau. This will affect the number of patients seeking care from PIH's seven Central Plateau
sites greatly.
In order to facilitate the movement of goods into Port Au Prince post quake, PIH has
rented a large facility in the city. It currently serves as a warehouse for goods and provides PIH
with a sense of how an additional large warehouse could help with the flow of goods. PIH is
uncertain whether it will continue renting this facility in the long-term. It has not been ruled out
that a facility in Port au Prince could someday serve as an additional centralized warehouse.
Post-earthquake, the plans for the proposed hospital in Mirebalais accelerated quickly
from a potential site to a definite site. There is also discussion of constructing a large warehouse
at this site. However, at the time of the writing of this thesis, the warehouse construction plans
are far from definitive.
7.3 Compounding Issues
Several intangible issues affect the PIH inventory system in Haiti, including hoarding,
untimely reporting of stockouts, and political issues. PIH Boston staff considers hoarding to be
an issue at the site level. If sites are uncertain if or when they will receive a stock, they will often
request more than they actually need as a hedge. Hoarding has long term effects, as it skews the
demand figures for that site.
Sites are also guilty of not requesting a good until its inventory is depleted, or has been
depleted for some time. Not only does this create an unnecessary emergency order to be
generated, but it also skews the reported demand for that product.
Political issues are another source of problems to PIH. Security problems can undermine
the safe transportation between sites, and politics often influences the selection of locations for
new sites.
8 Recommendations and Conclusion
8.1 Central Warehouse
Even with improved inventory policies, the current size of the second level of the central
warehouse is barely large enough to support required storage of goods. One potential area for
improvement would be more appropriate shelving. Use of shorter distances between shelves
containing smaller items or use of a bin system could allow for additional goods to be stored on
the shelves. As stated previously, the use of shelving in the central warehouse is exclusive to
those items which will remain for use in the Cange complex. Based on current site usage
numbers, limiting shelf usage to only the Cange site does not maximize the amount of goods that
could be stored on the shelves. However, with the changes of catchment population the
earthquake has brought, this may change.
Another potential area for improvement would be better usage of the lower level of the
warehouse. If a portion of the lower level could be used to store the products discussed in this
thesis, less aggressive inventory policies could be pursued.
8.2 IDA Order
IDA has made two offers to PIH that would improve stock keeping and stock levels. The
first offer was to color code boxes of goods for PIH prior to their shipment to PIH. These color
coded boxes could be used to differentiate between categories of products or intended final user
(site).
IDA has also offered to decrease lead times on goods if PIH can provide a forecast to
IDA with estimated needs prior to their annual order. This "heads up" would allow IDA to obtain
goods before the order is finalized. PIH has been reticent to follow through with this offer,
though, as it does not feel confident providing such information.
8.3 Inventory Policies
If PIH were a for-profit company in which processes could be easily changed, we
would recommend shifting to a monthly periodic review policy. Ordering products every
month results in a much lower inventory volume, while sacrificing less than $2000
annually in terms of additional emergency procurement costs. Furthermore, the inflow of
shipping containers is much more manageable as approximately one container arrives
each month, as opposed to ten containers arriving over a three to four months.
However, PIH has indicated that moving to monthly orders may be too onerous for
its Haiti staff. Additionally, it is likely that the annual cost of placing and receiving orders
would increase with more frequent shipments due to customs and the increased variable
cost associated with sending more partially filled containers. Therefore, changing to
quarterly or semi-annual review policies would be preferable to annual orders. Doing so
will significantly free up warehouse space without causing an increase in emergency
procurement costs. Additionally, more frequent shipments will make the warehouse more
manageable and allow for easier tracking of PIH's products.
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Appendix: Additional Tables and Figures
Total
Total Volume -
Toal_ Single Unit Volume Annual Unit
Description
Acetazolamide250mgTablet
Acetysalicyicacid500mgTablet
Acyclovir200mgTablet
Aninophylline25mg/ml10mlAmpulle
Amoxycillin125mgBottle
Amoxycillin500mgTablet
Amoxilline/AcideClav200/28.5228 5mgTablet
AmphotecirineB50mgAmpulle
AmpicillinlgOther
AlenololOmgTablet
PenicillinBenzathine2 4MIUAmpulle
Acidbenzoic6%+Acidsalicilic3%40mgOther
BenzylPenicillin5MIUAmpulle
CalciumGluconatelO%1(item)Ampulle
Captopril25mgTablet
Carbomazepine200mgTablet
Cephalexine500mgTablet
#units UnitQuan
6 1000
650 1000
300 500
50 100
1325 40
3700 1000
1000 50
150 1
1500 50
350 1000
550 50
350 10
100 s0
50 20
2000 100
250 1000
700 100
Order
6 000
650 000
150 000
5 000
53 000
3,700 000
50 000
150
75 000
350 000
27500
3 500
6 000
1 000
200 000
250 000
70 000
Volume m3 Volume m3
000000167 000166667
000000062 0 00061538
000000100 00605
0 00000560 0 0056
000042151 0 01686038
000000256 000255946
000001560 0 00078
0 00006667 6 6667E-05
0 00005573 0 00278667
0 00000066 0 00065714
000005527 000276364
000021714 000217143
0 00008600 00943
000005000 8 001
000000120 000012
000000120 00012
000000243 000024286
Order M3 Demand M3
001
040 0 00
0 15 0 05
0 28 0 04
2234
947 4 91
078
0 01
4 18 2 11
023 0 06
162 028
076 0 19
043
0 05
0 24 0 67
0 30 0 10
0 17 0 10
Weight KG
0 00166667
000061536
0 0005
0 0056
0 01686038
0 00255946
000078
6 6667E-05
0 00278667
0 00065714
0 00270364
0 00217143
0 0043
0 001
000012
0 0012
0 00024286
Total
Weight KG
lin kg})
4.5
117
150
974
9010
3182
125
3
2115
70
676 5
218 8
206
16 5
70
725
98
Unit Price/Qu Annual
Price antity Total Cost Demand9 Demand/Orde
2003 002003 120 18
195 000195 1,26750 4,620 1%
1249 002498 3.74700 45694 30%
4417 0,4417 2,20850 792 16%
1933 0,48325 25,61225
33.6 0 0336 124 320 00 1 918 142 52%
872 01744 8,72000
1151 1151 1,72650
1235 0247 1862500 37813 50%
642 000642 2247 00 91,529 26%
4306 08612 23683 00 5.056 18%
406 0405 141750 887 25%
4334 08668 4.33400
426 0.213 21300
1 26 0 0126 2.620 00 67 240 279%
1382 001382 3.46600 82,000 33%
1068 01068 7.47600 43009 61%
Figure Al: Product Details Tab
Product
Gentamycineeyedrops0.3%10mlOther
TetracyclineHydrochloride1%5gOther
Timololeyedrops0.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/150ltabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudine150mgTablet
LamivudineSuspension10mg/1Oml240mlBottle
Lopinavir/Ritonavir250mgTablet
Feb-10 Mar-10 Apr-10
2,663 2,615 2,546
3,857 3,972 4,006
607 594 583
7,887 7,712 7,455
1,319,751 1,316,952 1,319.746
893 902 923
104,997 103,308 102,608
486,545 487.788 488.935
50,470 50,530 50,555
1,164,412 1.178,370 1,199,676
967 940 930
149,829 151.352 155,013
Figure A2: Reorder Point Tab
Product
Gentamycineeyedrops0.3%10mlOther
TetracyclineHydrochloride1%5gOther
TimololeyedropsO.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudinel50mgTablet
LamivudineSuspension10mg/10m240mBottle
Lopinavir/Ritonavir250mgTablet
Feb-10
2,663
3,857
607
7,887
1.319,751
893
104,997
486,545
50,470
1. 164,412
967
149,829
Mar-10
2,615
3,972
594
7.712
1,316,952
902
103,308
487.788
50.530
1,178,370
940
151,352
Apr-10
2.546
4.006
583
7,455
1.319.746
923
102.608
488,935
50,555
1,199.676
930
155.013
May-10
2,468
3,957
576
7,337
1.328,837
936
103,304
488.963
50,617
1,218,840
942
159.650
Jun-10
2,363
3,873
569
7,368
1,337,826
942
104,456
488.710
50,658
1,230,565
969
164.618
Jul-10 Aug-10
2,259 2,207
3,826 3,871
550 523
7,704 8,339
1.352,964 1.371,495
922 888
104,564 102.692
491,811 500,794
50,369 50,069
1,238.743 1,253,781
1,013 1,070
170.173 183.493
Figure A3: Order up to Level Tab
Typea
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
May-10
2,468
3,957
576
7,337
1.328.837
936
103,304
488.963
50 .617
1,218,840
942
159,650
Jun-10
2,363
3,873
569
7,368
1,337,826
942
104,456
488,710
50,658
1,230,565
969
164.618
Jul-10
2,259
3826
550
7 704
1.352.964
922
104,564
491 811
50.369
1,238.743
1,013
170,173
Aug-10
2,207
3,871
523
8,339
1,371,495
888
102,692
500,794
50,069
1,253,781
1,070
183,493
Eyear
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
Product
Gentamycineeyedrops0 3%10mlOther
TetracyclineHydrochloride1%SgOther
Timololeyedrops0.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/150ltabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400ngTabet
Lamivudine150mgTablet
LamivudineSuspensionl0mg/1Oml240mlBo
HIV Lopinavir/Ritonavir250mgTablet
Feb-10 Mar-10
0 247
324 108
24 0
753 923
119,027 132.932
4 28
0 16,090
36,615 47,807
4,360 4,879
128,718 105,105
67 78
15.890 17,240
Figure A4: Demand Amounts on Simulated Demand Tab
GentamycineeyedropsO 3%10mlOther
TetracyclineHydrochloridel%SgOther
Timololeyedrops0.25%10mlOther
Abacavir300rngTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudine150mgTablet
0.810055
0.742197
0.401011
0.938749
0.738382
0.167493
0.189817
0.533664
0.509074
0.887957
0-688397
0.208592
0.061705
0.922482
0.860461
0.350607
0-868536
0.847779
0.721611
0.61416
LamivudineSuspensionl0mg/lOml240mlBo 0 155608 0.149753
Lopinavir/Ritonavir250rngTablet 0.596788 0.704034
Figure A5: Random Numbers at the Bottom of the Simulated Demand Tab
Gentamycineeyedrops0.3%10mlOther
TetracyclineHydrochloride 1 %5gther
Timololeyedrops0.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudine150mgTablet
LamivudineSuspension 10mg/1 OmI240mlBottle
Lopinavir/Ritonavir250mgTablet
2/28/2010 3/31/2010 4/30/2010 5/31/2010 6/30/2010 7131/2010 8/31/2010 9/30/2010 10/31/2010 11/30/2010
Figure A6: Emergency - Monthly Orders Tab
Type
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
Apr-10
325
215
27
659
147,225
0
9,003
47,231
5.533
94.158
101
20,456
May-10
83
399
94
1,317
117,568
60
0
48,920
4,176
138.527
126
13.661
Jun-10
428
323
69
1.026
96,835
85
9,321
41,460
4,104
113,059
125
20,406
J-10
559
444
32
450
113,655
68
4,197
59.802
5.195
120,967
144
8.202
Aug-10
130
487
29
954
160,269
24
10.412
43.327
5,269
49,756
91
11,507
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
0-809566
0.349933
0.46552
0.055993
0-923943
0.062317
0.737999
0.688337
0.928435
0.414374
0.3191
0.907018
0.132136
0.706638
0.910274
0.988498
0.390339
0.616249
0.253862
0.630272
0.415172
0.965592
0713981
0.232873
0.890704
0.505149
0.730783
0.791216
0.08313
0.650636
0.771121
0.25394
0.27798
0.673896
0.781603
0.899978
0.990337
0.872906
0.356974
0.016922
0.242009
0.420233
0.566682
0.942295
0.731457
0.853068
0.984642
0.493852
0.273993
0.903942
0.338519
0.935626
0.940956
0. 150582
0.764301
0.451039
0.800633
0.010689
0 794917
0.7685
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
Product
Gentamycineeyedrops0.3%10mlOther
TetracyclineHydrochloride1%SgOther
TimololeyedropsO.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efarenz600mgTablet
Indinavir400mgTablet
Lamivudine150mgTablet
LamivudineSuspension10mg/1Oml240mlBottle
Lopinavir/Ritonavir250mgTablet
2/28/2010 3/31/2010 4/30/2010 5/31/2010
2,848
3,949
628
7,563
1,318,285
981
115,471
493.492
51,105
1,167,760
977
152,192
2,601
3,840
628
6,640
1,185,353
953
99,381
445,685
46,226
1.062,655
899
134,952
2,276
3.626
601
5,981
1,038,128
953
90,379
398,455
40,693
968.497
798
114,496
2.193
3.227
508
4,664
920,560
893
90,379
349,535
36.517
829.970
672
100,835
Figure A7: Physical Stock - Annual Orders
Product
Gentamycineeyedrops0.3%10mlOther
TetracyclineHydrochloridel%5gOther
TimololeyedropsO.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudine150mgTablet
LamivudineSuspension1Orng/1OmI24OmlBottle
Lopinavir/Ritonavir250mgTablet
2/28/2010 3/31/2010 4/30/2010
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Figure A8: Emergency - Annual Orders Tab
Product
Gentamycineeyedrops0 3%10mlOther
TetracyclineHydrochlorde 1 %SgOther
TimoIoleyedrops0 25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudinel60mgTablet
LamivudineSuspension10mg/1O0ml240mlBottle
LopinavrRitonavir250mgTablet
3/1/2010 4/112010 5/1/2010 6/11/2010 7/1/2010 8/1/2010 9/1/2010 10/1/2010 11/1/2010 12/1/2010
0 0 0 0 0 0 003 0 0 0,042
0 0 0 0 0 0 0.049077 0 0 0.046846
0 0 0 0 0 0 0.00096 0 0 000286
Figure A9: Container Arrival Tab (no volume data for HIV drugs)
Tyee
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
6/30/2010
1,765
2.904
439
3.638
823.725
808
81,057
308,075
32,412
716,911
547
80,429
7/31/2010
1,207
2,460
407
3.189
710.070
740
76,860
248,273
27,218
595.943
403
72,227
8/31/2010
1,076
1,972
378
2,235
549,801
717
66,448
204.946
21 949
546,187
312
60,720
Eyper
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
5/31/2010
0
0
0
0
0
0
0
0
0
0
0
0
6/30/2010
0
0
0
0
0
0
0
0
0
0
0
0
7/31/2010
0
0
0
0
0
0
0
0
0
0
0
0
8/31/2010
0
0
0
0
0
0
0
0
0
0
0
0
Iype
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
Product
GentamycineeyedropsO.3%10mlOther
TetracyclineHydrochloride1%5gOther
Timololeyedrops0.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/150ltabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudine160rmgTablet
3/31/2010 4/30/2010
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
HIV LamivudineSuspension 10mg/1 Omt240mlBottle
HIV Lopinavir/Ritonavir250mgTablet
1/2010 6/30/2010 7/31/2010 8/31/2010
500 500
1,100 1,100
48 48
1,900 1,900
94.000 394,000
100 100
21,600 21,600
33,400 133,400
14.800 14,800
36,100 336,100
100 100
43,400 43.400
Figure A10: In-transit Stock Tab
Product
Gentamycineeyedrops0.3%10mlOther
TetracyclineHydrochloride1%5gOther
Timololeyedrops0.25%10mlOther
Abacavir300mgTablet
AZT+3TC300/1501tabTablet
Didanosine200mgTablet
Efavirenz200mgTablet
Efavirenz600mgTablet
Indinavir400mgTablet
Lamivudine150mgTablet
LamivudineSuspension10mg10m240mBottle
Lopinavir/Ritonavir250mgTablet
2/28/2010
2,095
2,268
447
5,401
846,770
645
85.570
320,260
32 057
701,408
728
94,765
3/31/2010
1,848
2,160
447
4,477
713,838
617
69,479
272,454
27 178
596,303
649
77 525
4/30/2010
1,523
1,945
420
3,818
566,613
617
60,477
225,223
21,644
502. 145
548
57.069
5/31/2010 6/30/2010 7/31/2010 8/31/2010
1,940
2,646
374
4.401
843,045
658
82,077
309,703
32,268
699,718
523
86.807
1.512
2,323
305
3,375
746,210
572
72,755
268,243
28,164
586,659
398
66.401
954
1,879
273
2.926
632,555
504
68 .559
208,442
22,969
465691
254
58 199
1.624
2.442
387
3.672
767.286
681
75 347
295,914
30,700
840.435
563
104.893
Figure Al1: Physical + In-transit Stock Tab
L=2,R=1, S=s
1
2
3
4
5
6
7
8
9
10
11
12
13
2/28/2010
0
0
0
0
0
0
0
0
0
0
0
0
474.4279
Figure A12: Emergency Procurement Sims Tab
Typer
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
500
1.100
48
1,900
394.000
100
21,600
133,400
14800
336,100
100
43.400
1,200
2.150
191
3,600
689.000
300
38.800
264,200
27.800
760,600
500
101,600
Tygee
EyeCare
EyeCare
EyeCare
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
HIV
3/31/2010
1.529094
2.010361
0
0
0
0
0
1.786065
0
22.48213
0.942614
37.36208
3767.885
4/30/2010
754.9361
951.9289
81.18212
145.5624
913.9205
95.20619
485.6311
1902.317
129.2144
99.81429
1427.077
216.8549
884.3781
5/31/2010
1108.68
1680.435
87.11694
340.5019
915.5154
652.0485
129.9745
948.7163
438.4999
300.5753
1075.555
24.54711
1066.366
6/30/2010
2459.653
581.424
64.49318
39.81957
76.6351
449.3989
875.6231
560.461
715.1361
88.67926
174.6578
438.8139
622.9787
7/31/2010
414.7972
377.669
169.8114
20.2967
241.9465
1506.502
199.0163
54.86108
308.6196
3540.932
644.9992
135.9448
95.81842
8/31/2010
436.8792
22.93716
426.0513
568.9099
589.299
107.5392
181.8347
337.5746
631.2162
1696.734
76.54977
124.1808
1056.691
5/3
3
1
3
L=2,R=1, S=s 2/28/2010 3/31/2010 4/30/2010 5/31/2010 6/30/2010 7/31/2010 8/31/2010
107.3425 62.15246 61.60583
89.74997 51.81979 57.24979
107.2775 71.42244 62.44629
89.82356 42.57616 52.34394
96.22331 50.82569 61.62839
108.9685 63.24501 66.68482
93.56144 55.17992 64.49739
105.2881 56.63884 53.0896
101-7647 59.00005 47 15901
98.27845 53.35294 51.98968
100.2181 52.88786 58.84486
106.0822 61-7072 59.86537
87713 44-65695 59-04087
55.77249 59.87705 62.79633
64.17462 51.63648 49.53593
68.00204 64.72125 72.60621
59.69051 61.88461 61.25429
61.94106 63.15993 58.51918
61.16927 56.45975 46.06539
65.45464 56.28977 52.01657
59.05828 69.3456 66.00748
54.5327 49.34911 49.73985
61.18116 51.58056 56.95356
52.25837 53.63829 57.45345
63.06185 65.2194 63.63126
62.23452 55.53812 56.28308
Figure A13: Volume Sims Tab
L=2,R=1. S=s
1
2
3
4
5
6
7
8
9
10
11
12
13
3/1/2010 4/1/2010 5/1/2010 6/1/2010
0 0 0.884954 0.814685
0 0 0.897424 0.96387
0 0 0.689938 0.852325
0 0 0.97681 0.882392
0 0 0.931046 0.811467
0 0 0.723014 0.786295
0 0 0.943488 0.846635
0 0 0.675501 0-898234
0 0 0.679093 0.966292
0 0 0.775757 0.930039
0 0 0.938562 0.728068
0 0 0.757901 0.800544
0 0 1.151512 0.892644
7/1/2010
0.775654
0.615473
0.577122
0.792299
0.754297
0-764506
0.624262
0.811194
0.705791
0.744091
0-807414
0.741482
0.711669
8/1/2010 9/1/2010
0.748671 0.904967
0.794902 0.685109
0.768405 0.623926
0.712467 0.630217
0.641477 0.690428
0.571067 0.785166
0.687698 0.712333
0.657404 0.664415
0.802184 0.717143
0.726779 0.627832
0.726198 0.718958
0.694901 0.640594
0.72485 0.678222
Figure A14: Container Arrival Tab
148.8269
142.1537
153.7051
137.9841
140.4507
151.925
139.9142
154.7294
154.2446
149.2292
140.04
149.8751
129.4594
